← Open Payments lookup

IQUO ANDREWS-COOPER: Open Payments

NPI 1992182117 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$558 in 31 payments from 9 companies in 2025. Trend: 2023 $622 · 2024 $546 · 2025 $558

Food & beverage: $558
CompanyPaymentsAmount
ABBVIE INC.15$201
Teva Pharmaceuticals USA, Inc.4$81
Neurocrine BioSciences, Inc.3$70
Otsuka America Pharmaceutical, Inc.3$63
Vanda Pharmaceuticals Inc.2$42
E.R. Squibb & Sons, L.L.C.1$37
Janssen Pharmaceuticals, Inc1$24
Alkermes, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: VRAYLAR, INGREZZA, HETLIOZ, ABILIFY MAINTENA, AUSTEDO XR, UZEDY, COBENFY, INVEGA SUSTENNA.

Industry payments across MD — which companies pay providers there.